Patients with major depressive disorder often exhibit lower SERT expression, and studies have shown that estrogen and antiandrogen medications reduce regional SERT binding in transwomen, whereas androgen therapy increases SERT binding in different brain regions in transmen. Here, SLC6A4 is linked to major depressive disorder.